232 related articles for article (PubMed ID: 12013364)
21. Atypical neuroleptic malignant syndrome - A case report.
Vellekkatt F; Kuppili PP; Bharadwaj B; Menon V
Asian J Psychiatr; 2019 Jun; 43():7-8. PubMed ID: 31071486
[TBL] [Abstract][Full Text] [Related]
22. Atypical antipsychotics and neuroleptic malignant syndrome.
Kohen D; Bristow MF
Br J Psychiatry; 1999 Oct; 175():392-3. PubMed ID: 10789314
[No Abstract] [Full Text] [Related]
23. Possible neuroleptic malignant syndrome associated with olanzapine.
Nyfort-Hansen K; Alderman CP
Ann Pharmacother; 2000 May; 34(5):667. PubMed ID: 10852098
[No Abstract] [Full Text] [Related]
24. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
25. Olanzapine treatment in patients with typical and atypical neuroleptic-associated agranulocytosis.
Finkel B; Lerner A; Oyffe I; Rudinski D; Sigal M; Weizman A
Int Clin Psychopharmacol; 1998 May; 13(3):133-5. PubMed ID: 9690981
[TBL] [Abstract][Full Text] [Related]
26. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
Aboraya A; Schumacher J; Abdalla E; LePage J; McGhee M; Butcher D; Griffin H; Shahda M
W V Med J; 2002; 98(2):63-5. PubMed ID: 12048741
[TBL] [Abstract][Full Text] [Related]
27. Olanzapine and NMS.
Hickey C; Stewart C; Lippmann S
Psychiatr Serv; 1999 Jun; 50(6):836-7. PubMed ID: 10375159
[No Abstract] [Full Text] [Related]
28. Atypicality in presentation of neuroleptic malignant syndrome caused by olanzapine.
Mishra B; Mishra B; Sahoo S; Arora M; Khess CR
Indian J Med Sci; 2007 Oct; 61(10):570-3. PubMed ID: 17932448
[TBL] [Abstract][Full Text] [Related]
29. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
Picard LS; Lindsay S; Strawn JR; Kaneria RM; Patel NC; Keck PE
Pharmacotherapy; 2008 Apr; 28(4):530-5. PubMed ID: 18363536
[TBL] [Abstract][Full Text] [Related]
30. Neuroleptic malignant syndrome in a child treated with an atypical antipsychotic.
Abu-Kishk I; Toledano M; Reis A; Daniel D; Berkovitch M
J Toxicol Clin Toxicol; 2004; 42(6):921-5. PubMed ID: 15533033
[TBL] [Abstract][Full Text] [Related]
31. Atypical neuroleptic malignant syndrome caused by olanzapine.
Nielsen J; Bruhn AM
Acta Psychiatr Scand; 2005 Sep; 112(3):238-40; discussion 240. PubMed ID: 16095481
[TBL] [Abstract][Full Text] [Related]
32. [Malignant neuroleptic syndrome in treatment with the new, atypical antipsychotic agents, risperidone and olanzapine].
Gram LF
Ugeskr Laeger; 2000 Mar; 162(13):1914-5. PubMed ID: 10765710
[No Abstract] [Full Text] [Related]
33. Neuroleptic malignant syndrome associated with olanzapine.
Johnson V; Bruxner G
Aust N Z J Psychiatry; 1998 Dec; 32(6):884-6. PubMed ID: 10084355
[TBL] [Abstract][Full Text] [Related]
34. Neuroleptic malignant syndrome due to three atypical antipsychotics in a child.
Chungh DS; Kim BN; Cho SC
J Psychopharmacol; 2005 Jul; 19(4):422-5. PubMed ID: 15982999
[TBL] [Abstract][Full Text] [Related]
35. Neuroleptic malignant syndrome after addition of haloperidol to atypical antipsychotic.
Mujica R; Weiden P
Am J Psychiatry; 2001 Apr; 158(4):650-1. PubMed ID: 11282706
[No Abstract] [Full Text] [Related]
36. Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy.
Stevens DL; Lee MR; Padua Y
Pharmacotherapy; 2008 Mar; 28(3):403-5. PubMed ID: 18294120
[TBL] [Abstract][Full Text] [Related]
37. Neuropletic malignant syndrome and olanzapine.
Sierra-Biddle D; Herran A; Diez-Aja S; Gonzalez-Mata JM; Vidal E; Diez-Manrique F; Vazquez-Barquero JL
J Clin Psychopharmacol; 2000 Dec; 20(6):704-5. PubMed ID: 11106147
[No Abstract] [Full Text] [Related]
38. Tardive dystonia associated with olanzapine therapy.
Gunal DI; Onultan O; Afsar N; Aktan S
Neurol Sci; 2001 Aug; 22(4):331-2. PubMed ID: 11808858
[TBL] [Abstract][Full Text] [Related]
39. Olanzapine associated weight gain, hyperglycemia and neuroleptic malignant syndrome: case report.
Malyuk R; Gibson B; Procyshyn RM; Kang N
Int J Geriatr Psychiatry; 2002 Apr; 17(4):326-8. PubMed ID: 11994885
[TBL] [Abstract][Full Text] [Related]
40. Possible neuroleptic malignant syndrome associated with paliperidone.
Duggal HS
J Neuropsychiatry Clin Neurosci; 2007; 19(4):477-8. PubMed ID: 18070861
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
